Stryker develops and manufactures orthopedic implants for joint replacements and trauma, along with medical and surgical equipment such as power tools, stretchers, endoscopy systems, and patient handling devices. Its products are used primarily by hospitals, surgeons, and emergency responders in over 75 countries to support surgical procedures, critical care, and mobility. The company maintains a broad portfolio across orthopedics, neurotechnology, and spine segments, supported by ongoing product innovation and acquisitions.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 6,022 | — | 884 | — |
| Q3 2025 | 6,057 | — | 859 | — |
| Q4 2025 | 7,171 | — | 849 | — |
| Q1 2026 | 6,020 | — | 745 | — |
| Q2 2026 | 6,589 | 9.4% | 1,276 | 44.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Parker-Hannifin Corporation (PH), CVS Health Corporation (CVS), British American Tobacco p.l.c. (BTI), Petróleo Brasileiro S.A. - Petrobras (PBR A), Bank of Montreal (BMO), HDFC Bank Limited (HDB)